Arthroscopic Scapholunate Ligament Reconstruction
Launched by REGIONAAL ZIEKENHUIS HEILIG HART TIENEN · Jan 23, 2024
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a specific surgical technique called arthroscopic reconstruction to treat a condition known as scapholunate dissociation. This condition happens when a key ligament in the wrist is completely injured, which can lead to pain and problems with wrist function. The study aims to find out how well this surgery works over time, focusing on both short-term and mid-term results for patients.
To participate in this trial, individuals need to be between the ages of 18 and 65 and have a specific type of wrist ligament injury that can be treated with this method. They should not have any other serious wrist injuries, arthritis, or neurological disorders affecting their upper limb. If eligible, participants will undergo the surgical procedure and will be monitored to assess their recovery and wrist function afterward. It's important to note that the trial is not yet recruiting participants, so there will be more information available once it opens.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Scapholunate dysfunction, complete irrepairable lesion of the SL ligament and the secondary stabilizers (RSC-LRL-SRL) EWAS stage 4-5, no arthritis, with reducible malalignment
- • 18 - 65 years
- Exclusion Criteria:
- • - associated lesions, fractures
- • neurological disorder affecting the upper limb, history of wrist lesion involving the same wrist, dementia, substance abuse, severe psychiatric disorder and previous injured contralateral wrist
About Regionaal Ziekenhuis Heilig Hart Tienen
Regionaal Ziekenhuis Heilig Hart Tienen is a leading healthcare institution located in Tienen, Belgium, dedicated to providing high-quality medical care and fostering innovative clinical research. With a commitment to patient-centered services, the hospital integrates advanced medical practices and state-of-the-art facilities to enhance treatment outcomes. The institution actively engages in clinical trials across various therapeutic areas, aiming to contribute to the advancement of medical science and improve patient care. Through collaboration with healthcare professionals and research organizations, Regionaal Ziekenhuis Heilig Hart Tienen is at the forefront of translating research findings into effective clinical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tienen, , Belgium
Patients applied
Trial Officials
Kjell Van Royen, MD
Study Chair
Universitair Ziekenhuis Brussel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported